Also, an anti-CTLA-4 DNA aptamer [20] and a dual function aptamer (anti-CTLA-4/PD-L1) [21] have shown that an anti-CLTA-4 aptamer can promote T lymphocyte proliferation, inhibit tumor growth, and strengthen anti-tumor immunity. Here, CD274 is linked to neoplasm.